| 摘要 |
A pharmaceutical composition, which composition comprises: 5- 4- 2-(N-methyl N- (2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2,4-dione or metformin, wherein the composition is arranged to provide amodified release of at least one of the insulin sensitiser and the other antidiabetes agent, and the use of such composition in medicine.
|
